| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.00036 | 1 |